治疗支架市场预计在 2024 年至 2031 年期间的复合年增长率为 6.8%,市场规模将从 2024 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。
报告按产品(冠状动脉支架、外周支架、其他)进行细分。报告进一步根据应用(医院、心脏中心、门诊手术中心)进行分析。全球分析进一步细分为区域和主要国家。报告以美元为单位提供上述分析和细分的价值。
报告目的
Insight Partners 撰写的《治疗支架市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:
- 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
- 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
- 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。
治疗支架市场细分
产品
- 冠状动脉支架
- 外周支架
- 其他的
应用
- 医院
- 心脏中心
- 门诊手术中心
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
治疗支架市场的增长动力
- 心血管疾病发病率上升:心血管疾病 (CVD) 在世界范围内的发病率不断上升,这是治疗支架市场增长的主要因素之一。在冠状动脉疾病和外周动脉疾病等情况下,进行支架植入术是为了改善血流并避免进一步的并发症。
- 支架技术进步:支架和材料的新设计,例如用于预防再狭窄的药物洗脱支架,正在改善治疗效果。这些进步使支架的使用更加高效和安全,从而提高了其在临床医学中的应用。
- Increasing Geriatric Group: With the world’s population becoming older, there is also a rise in age-related health problems such as cardiovascular diseases. This shift is contributing to the higher need for therapeutic stents as a larger number of people need interventions to treat and manage their diseases.
Therapeutic Stents Market Future Trends
- Regenerative Medicine Applications: The use of principles of regenerative medicine in stenting devices, for example, the development of endothelial cell-seeded stents, offers exciting trends in the market. These innovations look to enhance healing and minimize complications, which makes them appealing to both the patients and the healthcare providers.
- Integration of Drug Delivery Systems: The trend for the development of stents with incorporated advanced drug delivery systems is likely to increase. These systems can typically provide localized therapy directly at the stented site, minimizing the chances of restenosis and enhancing the outcome.
- Emergence of Biodegradable Stents: Researchers focus on biodegradable stents, which are often designed to dissolve over a period of time. Replacing long-lasting implants with an absorbable stent may greatly help in mitigating the complications associated with such implants. As further clinical studies open their efficacy and safety, this innovation is expected to shape the future of the industry.
Therapeutic Stents Market Opportunities
- Promotion and Expansion of Screening Programs: Enhanced knowledge of cardiovascular well-being and the significance of timely interventions are triggering an upsurge in the number of screenings and diagnoses. This creates a higher demand for therapeutic stents as patients are increasingly looking for treatment options.
- Investment in Healthcare Infrastructure: The gradual increase in expenditure for healthcare infrastructure, mostly in low-income countries, has opened up the availability of advanced equipment such as therapeutic stents. More facilities with the adoption of these devices are anticipated to increase, hence favouring market expansion.
- Inclusion of Drug-Eluting Technologies: The potential combining of therapeutic drugs into the design of a stent holds great potential for the growth of sector. The use of drug-eluting stents (DES), which extend the release of drugs to prevent restenosis, is gaining wider use. These stents will have higher rates of acceptance due to the advent of new therapeutic agents and better drug delivery systems.
Therapeutic Stents Market Regional Insights
The regional trends and factors influencing the Therapeutic Stents Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Therapeutic Stents Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

- Get the Regional Specific Data for Therapeutic Stents Market
Therapeutic Stents Market Report Scope
报告属性 | 细节 |
---|---|
2024 年的市场规模 | XX 百万美元 |
2031 年市场规模 | XX 百万美元 |
全球复合年增长率(2024 - 2031) | 6.8% |
史料 | 2021-2023 |
预测期 | 2025-2031 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
治疗支架市场参与者密度:了解其对业务动态的影响
治疗支架市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在治疗支架市场运营的主要公司有:
- 雅培实验室
- B. Braun Melsungen AG
- Biotronik SE & Co. KG
- 波士顿科学公司
- CR 巴德
免责声明:上面列出的公司没有按照任何特定顺序排列。

- 了解治疗支架市场的主要参与者概况
主要卖点
- 全面覆盖:报告全面涵盖了治疗支架市场的产品、服务、类型和最终用户的分析,提供了整体概况。
- 专家分析:报告基于对行业专家和分析师的深入了解而编写。
- 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
- 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。
因此,治疗支架市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。
- 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
- PEST 和 SWOT 分析
- 市场规模价值/数量 - 全球、区域、国家
- 行业和竞争格局
- Excel 数据集



Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
常见问题
Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C.R. Bard, Elixir Medical Corporation, Medtronic plc, Microport Scientific Corporation, STENTYS SA, and Terumo Corporation are some of the major players operating in the market.
The coronary stents segment accounts for the highest revenue in product segment of the therapeutic stents market in 2023.
The Therapeutic Stents Market is estimated to witness a CAGR of 6.8% from 2023 to 2031
Asia Pacific region has the highest CAGR of the therapeutic stents market.
North America region dominated the therapeutic stents market in 2023.
The major factors driving the therapeutic stents market are:
1. Rise in Incidence of Cardiovascular Diseases.
2. Technological Advancements in Stents.
3. Increasing Geriatric Group.
Trends and growth analysis reports related to Life Sciences : READ MORE..
1. Abbott Laboratories
2. B. Braun Melsungen AG
3. Biotronik SE & Co. KG
4. Boston Scientific Corporation
5. C.R. Bard
6. Elixir Medical Corporation
7. Medtronic plc
8. Microport Scientific Corporation
9. STENTYS SA
10. Terumo Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.